PG
CRL icon

PEAK6 Group’s Charles River Laboratories CRL Stock Holding History

PEAK6 Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$561K Sell
5,000
-5,100
-50% -$551K ﹤0.01% 2487
2018
Q1 		$1.08M Buy
10,100
+9,900
+4,950% +$1.07M ﹤0.01% 1891
2017
Q4 		$22K Buy
+200
New +$21.8K ﹤0.01% 3873
2017
Q3 		– Sell
-10,100
Closed -$1.02M – 4478
2017
Q2 		$1.02M Buy
10,100
+1,700
+20% +$156K 0.01% 1910
2017
Q1 		$756K Buy
+8,400
New +$713K 0.01% 1917
2016
Q3 		– Sell
-6,300
Closed -$519K – 4352
2016
Q2 		$519K Buy
+6,300
New +$519K ﹤0.01% 2327
2016
Q1 		– Sell
-5,800
Closed -$466K – 4483
2015
Q4 		$466K Sell
5,800
-15,800
-73% -$1.14M ﹤0.01% 2646
2015
Q3 		$1.37M Sell
21,600
-12,900
-37% -$926K 0.01% 1903
2015
Q2 		$2.43M Buy
34,500
+34,200
+11,400% +$2.53M 0.01% 1321
2015
Q1 		$24K Sell
300
-2,500
-89% -$184K ﹤0.01% 4458
2014
Q4 		$178K Buy
+2,800
New +$176K ﹤0.01% 3449
2014
Q3 		– Sell
-1,200
Closed -$64K – 4736
2014
Q2 		$64K Sell
1,200
-59,200
-98% -$3.25M ﹤0.01% 3948
2014
Q1 		$3.64M Buy
+60,400
New +$3.52M 0.03% 830

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Group's CRL Position: Q2 2018 in Review

PEAK6 Group reduced its Charles River Laboratories (CRL) stake by 64% in Q2 2018, selling an estimated $875K and leaving 4,469 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

PEAK6 Group first reported a position in CRL in Q4 2013 and has held it in 13 quarters since. The position peaked at $1.81M in Q1 2014. 348 funds tracked by Wall St. Rank hold CRL as of Q2 2018.

  • PEAK6 Group held 4,469 shares of Charles River Laboratories worth $502K as of Q2 2018.
  • PEAK6 Group sold 8,098 Charles River Laboratories shares in Q2 2018, an estimated $875K.
  • Charles River Laboratories made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2590 holding.
  • PEAK6 Group first reported a position in Charles River Laboratories in Q4 2013 and has held it in 13 quarters since.
  • PEAK6 Group's Charles River Laboratories position peaked at $1.81M in Q1 2014.
  • 348 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.